4.7 Article

A new staging system for postoperative prognostication in pancreatic ductal adenocarcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Prognosis Based Definition of Resectability in Pancreatic Cancer A Road Map to New Guidelines

Atsushi Oba et al.

Summary: This study aims to identify objective preoperative prognostic factors for predicting long-term survival of patients with PDAC. The authors analyzed data from the National Cancer Database and developed a nomogram based on preoperative variables. The nomogram classified patients into three prognosis groups and showed promising results in predicting survival. This new concept of resectability based on tumor biology provides an improved approach for classifying PDAC patients beyond purely anatomical features.

ANNALS OF SURGERY (2022)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

Eva Versteijne et al.

Summary: This study investigates the impact of neoadjuvant chemoradiotherapy on the survival of patients with resectable and borderline resectable pancreatic cancer. The results demonstrate that neoadjuvant chemoradiotherapy improves overall survival compared to upfront surgery in these patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer

Thijs J. Schouten et al.

Summary: This study aimed to validate five proposed modifications to the 8th American Joint Committee on Cancer (AJCC) TNM staging system for pancreatic ductal adenocarcinoma. The results showed that the 8th edition still lacks prognostic value for some categories of patients, and the four previously proposed modifications did not clearly improve the situation. However, a new modification suggested in this study allows for better prognostication in patients with all stages of the disease.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade

Anna-Katharina Koenig et al.

Summary: The 8th edition of the TNM staging system for pancreatic cancer needs improvement, and integrating tumor grading into the system can further optimize prognostic stratification.
Article Surgery

Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer

Mark J. Truty et al.

Summary: This study aimed to identify predictive factors associated with operative morbidity, mortality, and survival outcomes in patients with BR/LA PDAC undergoing TNT. The results showed that independent factors associated with favorable survival outcomes in resected patients include extended duration chemotherapy, optimal post-chemotherapy CA19-9 response, and major pathologic response. Complete metabolic response highly correlated with major pathologic response in a subset of patients.

ANNALS OF SURGERY (2021)

Article Oncology

Preoperative CTC-Detection by CellSearch(R) Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer

Harald Hugenschmidt et al.

Summary: The presence of circulating tumor cells (CTCs) in preoperative samples of pancreatic cancer patients undergoing surgery was associated with earlier cancer metastasis and shorter survival, suggesting that CTCs may serve as a guide for initial treatment decisions in resectable pancreatic cancer patients.

CANCERS (2021)

Article Gastroenterology & Hepatology

Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)

Jae Seung Kang et al.

Summary: Several prediction models for evaluating the prognosis of resected PDAC have been developed and externally validated. Independent prognostic factors include age, sex, tumor location, T and N stages, histologic differentiation, and adjuvant chemotherapy. The developed model showed reliable performance with quantitative survival probabilities.

GUT AND LIVER (2021)

Article Oncology

Development and Validation of a Nomogram to Predict Survival in Pancreatic Head Ductal Adenocarcinoma After Pancreaticoduodenectomy

Feng Peng et al.

Summary: A nomogram was developed to estimate survival in patients with pancreatic head ductal adenocarcinoma (PHDAC) after pancreaticoduodenectomy (PD). The nomogram showed better predictive performance and clinical utility compared to traditional staging systems in both internal and external validation cohorts. This may improve prognosis-based patient selection for PD.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study

G. Houvenaeghel et al.

Summary: The presence of lymphovascular invasion (LVI) has an independent negative prognostic impact on overall, disease-free, and metastasis-free survival in early breast cancer patients, except in ER-positive grade 3 tumors and in those with luminal A-like tumors treated with adjuvant chemotherapy. This suggests that LVI may indicate a subset of luminal A-like patients who could benefit from adjuvant therapy.

ESMO OPEN (2021)

Review Medicine, General & Internal

Pancreatic Cancer: A Review

Wungki Park et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer with increasing incidence each year, resulting in a high percentage of patients being diagnosed with advanced disease. Current cytotoxic therapies for PDAC are moderately effective, emphasizing the importance of multidisciplinary management, comprehensive germline testing, and integrated supportive care for all patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Gastroenterology & Hepatology

The imaging features of extrapancreatic perineural invasion (EPNI) in pancreatic Cancer:A comparative retrospective study

Xiaofan Guo et al.

Summary: The study found that measuring the minimum distance between the tumor boundary and arteries is an effective imaging indicator for diagnosing EPNI; iPNI is an independent risk factor for DFS and OS; the novel typing method based on potentially invaded PLX may have guiding significance for surgical dissection.

PANCREATOLOGY (2021)

Article Oncology

Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020

Haibo Qiu et al.

Summary: Cancer is a major cause of death and economic burden in China, with lower incidence but higher mortality and DALY rates compared to the US and UK. The cancer spectrum in China is changing, with increasing burden of certain cancers and a shift towards patterns seen in developed countries.

CANCER COMMUNICATIONS (2021)

Article Oncology

Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis

Hao Hu et al.

Summary: The study validated the 8th AJCC staging system for PDAC in a Chinese cohort and developed a refined staging system for better prediction of patient survival. The N category was found to have better prognostic value than the T category. The modified staging system showed superior accuracy in predicting survival compared to the 8th AJCC TNM staging system.

CHINESE JOURNAL OF CANCER RESEARCH (2021)

Article Multidisciplinary Sciences

CA19-9 for detecting recurrence of pancreatic cancer

Azadeh Azizian et al.

SCIENTIFIC REPORTS (2020)

Article Gastroenterology & Hepatology

Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?

Omar Abdel-Rahman

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)

Article Gastroenterology & Hepatology

Multinational validation of the American Joint Committee on Cancer 8th edition pancreatic cancer staging system in a pancreas head cancer cohort

Wooil Kwon et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2018)

Article Gastroenterology & Hepatology

Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer

Yan-Hui Yang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Editorial Material Medicine, General & Internal

Decision Curve Analysis

Mark Fitzgerald et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)